“…However, the effectiveness of topically administered therapeutic nucleic acids is often diminished by low permeation efficiency across the skin due to the pertinent protective physical barriers, including the stratum corneum, nucleated epidermal layers, and tight junctions [ 10 ]. Several previous studies have reported that, not only the physical methods, such as electroporation, microneedles, or iontophoresis [ 11 , 12 , 13 , 14 ], but also nanocarriers, such as liposome, polymer or carbon nanotube, are capable of penetrating siRNAs in animal skin [ 15 , 16 , 17 ]. Additionally, one expected method of improving siRNAs permeation efficiency is the use of the cell penetrating peptides, including the arginine-rich transcriptional activator (TAT)-derived peptides [ 18 , 19 , 20 , 21 , 22 , 23 ].…”